<?xml version="1.0" encoding="UTF-8"?>
<fig id="f3-1030717" position="float">
 <label>Figure 3.</label>
 <caption>
  <p>Effect of tocilizumab administration on interleukin 6 and soluble interleukin 6 receptor levels based on conditioning regimen. (A). Concentration of IL-6 in the serum from patients that were treated with tocilizumab and received myeloablative or reduced intensity conditioning. (B). Concentration of soluble IL-6 receptor in the serum from patients that were treated with tocilizumab and received myeloablative or reduced intensity conditioning. ***
   <italic>P</italic>&lt;0.001. IL: interleukin; sIL: soluble interleukin; RIC: reduced intensity conditioning.
  </p>
 </caption>
 <graphic xlink:href="103717.fig3" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
